Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solutions to treat patients with chronic, rare, prevalent, and life-threatening diseases. It offers immunoglobulins, alpha-1 antitrypsin, albumin, clotting factors, and hyperimmune globulins. The Hospital division offers non-biological pharmaceutical products and medical supplies clinical nutrition, intravenous therapy, and medical devices. The Diagnostic division researches, develops, produces, and commercializes diagnostic products that span the healthcare continuumfrom prevention, screening, diagnosis, and prognosis to disease and treatment monitoringto serve professionals. The Bio Supplies division provides biological materials for life-science research, clinical trials, and for manufacturing pharmaceutical and diagnostic products. Its products and services are used by healthcare providers to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases, and other medical conditions. The company serves public and private customers; and wholesalers, distributors, group purchasing organizations, blood banks, hospitals and care institutions, and national health systems. Grifols, S.A. has a technology collaboration agreement with Mondragon. The company was founded in 1940 and is headquartered in Barcelona, Spain.
Grifols Dividend Announcement
• Grifols announced a annually dividend of $0.44 per ordinary share which will be made payable on 2021-06-14. Ex dividend date: 2021-06-03
• Grifols's trailing twelve-month (TTM) dividend yield is -%
Grifols Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2021-06-03 | $0.44 | annually | 2021-06-14 |
2020-10-30 | $0.20 | annually | 2020-11-09 |
2019-12-02 | $0.22 | annually | 2019-12-11 |
2019-06-07 | $0.17 | annually | 2019-06-18 |
2018-11-30 | $0.23 | annually | 2018-12-11 |
2018-06-01 | $0.25 | annually | 2018-06-12 |
2017-12-01 | $0.21 | annually | 2017-12-12 |
2017-05-30 | $0.16 | annually | 2017-06-08 |
2016-12-05 | $0.19 | annually | 2016-12-14 |
2016-06-02 | $0.16 | annually | 2016-06-15 |
2015-12-10 | $0.37 | annually | 2015-12-17 |
2015-06-08 | $0.34 | annually | 2015-06-15 |
2014-12-04 | $0.31 | annually | 2014-12-12 |
2014-06-05 | $0.29 | annually | 2014-06-13 |
2013-06-05 | $0.26 | annually | 2013-06-13 |
2013-05-29 | $0.01 | annually |
Grifols Dividend per year
Grifols Dividend growth
Grifols Dividend Yield
Grifols current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Grifols stock? Use our calculator to estimate your expected dividend yield:
Grifols Financial Ratios
Grifols Dividend FAQ
Other factors to consider when evaluating Grifols as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Grifols stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Grifols's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Grifols publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Grifols distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Grifols are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Grifols sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Grifols distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Grifols declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Grifols's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Grifols's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.